Aldeyra Therapeutics, Inc.
COMBINATION TREATMENT OF OCULAR INFLAMMATORY DISORDERS AND DISEASES

Last updated:

Abstract:

The present disclosure provides a combination of a fused bicyclic amine compound and an anti-inflammatory agent for treating ocular inflammatory disorders and diseases. Further provided are pharmaceutical compositions of the compound and the anti-inflammatory agent.

Status:
Application
Type:

Utility

Filling date:

23 Sep 2021

Issue date:

16 Jun 2022